These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37194008)

  • 1. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
    Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
    BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
    Merckx J; Callies M; Kabouche I; Desombere I; Duysburgh E; Roelants M
    Epidemiol Infect; 2023 Apr; 151():e75. PubMed ID: 37092673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
    Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
    J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
    Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
    Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.
    Meyers E; Deschepper E; Duysburgh E; De Rop L; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. School mask policies and SARS-CoV-2 seroprevalence among school-age children-United States, September to December 2021.
    Nycz E; Deng Y; Van Dyke ME; Bratcher A; Shi J; Iachan R; Berney K; Jones JM; Clarke KEN
    Microbiol Spectr; 2024 Oct; 12(10):e0069124. PubMed ID: 39194255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Transmission in Belgian French-Speaking Primary Schools: An Epidemiological Pilot Study.
    Frère J; Chatzis O; Cremer K; Merckx J; De Keukeleire M; Renard F; Ribesse N; Minner F; Ruelle J; Kabamba B; Rodriguez-Villalobos H; Bearzatto B; Delforge ML; Henin C; Bureau F; Gillet L; Robert A; Van der Linden D
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the clustering effect of the SARS-CoV-2 transmission in a school population: a cross-sectional study in a high incidence region.
    Severo M; Meireles P; Ribeiro AI; Morais V; Barros H
    Sci Rep; 2023 Sep; 13(1):16300. PubMed ID: 37770455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
    Meyers E; De Rop L; Deschepper E; Duysburgh E; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; De Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
    Eur J Gen Pract; 2023 Dec; 29(2):2149732. PubMed ID: 36440533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study.
    Ulyte A; Radtke T; Abela IA; Haile SR; Braun J; Jung R; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
    Int J Public Health; 2020 Dec; 65(9):1549-1557. PubMed ID: 33063141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 seroprevalence and mental health of school staff: a cross-sectional study of schools from four areas of Montreal, Quebec in 2021.
    Charland K; Pannunzio M; Greenspan-Ardman E; Saucier A; Pierce L; Hamelin ME; Barbosa Da Torre M; Carbonneau J; Tuong Nguyen C; De Serres G; Papenburg J; Boivin G; Quach C; Zinszer K
    BMJ Open; 2024 Aug; 14(8):e081838. PubMed ID: 39182934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England.
    Ladhani SN; Ireland G; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Aiano F; Amin-Chowdhury Z; Kall M; Borrow R; Linley E; Zambon M; Poh J; Warrener L; Lackenby A; Ellis J; Amirthalingam G; Brown KE; Ramsay ME
    J Infect; 2021 Nov; 83(5):573-580. PubMed ID: 34400220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    medRxiv; 2020 Oct; ():. PubMed ID: 33140066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November-December 2021 in the canton of Zurich.
    Haile SR; Raineri A; Rueegg S; Radtke T; Ulyte A; Puhan MA; Kriemler S
    Swiss Med Wkly; 2023 Jan; 153():40035. PubMed ID: 36787493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
    Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COVID-19 Sentinel Schools Network of Catalonia (CSSNC) project: Associated factors to prevalence and incidence of SARS-CoV-2 infection in educational settings during the 2020-2021 academic year.
    Ganem F; Bordas A; Folch C; Alonso L; Montoro-Fernandez M; Colom-Cadena A; Mas A; Mendioroz J; Asso L; Anton A; Pumarola T; González MV; Blanco I; Soler-Palacín P; Soriano-Arandes A; Casabona J;
    PLoS One; 2022; 17(11):e0277764. PubMed ID: 36395191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
    Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
    BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COVID-19 Schools Infection Survey in England: Protocol and Participation Profile for a Prospective Observational Cohort Study.
    Halliday KE; Nguipdop-Djomo P; Oswald WE; Sturgess J; Allen E; Sundaram N; Ireland G; Poh J; Ijaz S; Shute J; Diamond I; Rourke E; Dawe F; Judd A; Clark T; Edmunds WJ; Bonell C; Mangtani P; Ladhani SN; Langan SM; Hargreaves J;
    JMIR Res Protoc; 2022 Nov; 11(11):e34075. PubMed ID: 35635843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.